Neurodevelopment in schizophrenia: the role of the wnt pathways

Isabella Panaccione¹, Flavia Napoletano¹, Alberto Maria Forte¹, Giorgio D Kotzalidis¹, Antonio Del Casale¹, Chiara Rapinesi¹, Chiara Brugnoli¹, Daniele Serata¹, Federica Caccia¹, Ilaria Cuomo¹, Elisa Ambrosi¹, Alessio Simonetti¹, Valeria Savoja¹, Lavinia De Chiara¹, Emanuela Danese¹, Giovanni Manfredi¹, Delfina Janiri¹, Marta Motolese², Ferdinando Nicoletti³, Paolo Girardi⁴, Gabriele Sani⁵

Affiliations

¹ NESMOS Department (Neuroscience, Mental Health, and Sensory Organs), Sapienza University, School of Medicine and Psychology, Sant'Andrea Hospital, Rome, Italy;
² NEUROMED, Pozzilli, Isernia, Italy;
³ NEUROMED, Pozzilli, Isernia, Italy; ; Department of Neuropharmacology, Sapienza University, School of Medicine and Pharmacy, Rome, Italy;
⁴ NESMOS Department (Neuroscience, Mental Health, and Sensory Organs), Sapienza University, School of Medicine and Psychology, Sant'Andrea Hospital, Rome, Italy; ; Centro Lucio Bini, Rome, Italy;
⁵ NESMOS Department (Neuroscience, Mental Health, and Sensory Organs), Sapienza University, School of Medicine and Psychology, Sant'Andrea Hospital, Rome, Italy; ; Centro Lucio Bini, Rome, Italy; ; IRCCS Santa Lucia Foundation, Department of Clinical and Behavioural Neurology, Neuropsychiatry Laboratory, Rome, Italy.

PMID: 24403877
PMCID: PMC3763761
DOI: 10.2174/1570159X113119990037

Neurodevelopment in schizophrenia: the role of the wnt pathways

Isabella Panaccione et al. Curr Neuropharmacol. 2013 Sep.

. 2013 Sep;11(5):535-58.

doi: 10.2174/1570159X113119990037.

Authors

Affiliations

¹ NESMOS Department (Neuroscience, Mental Health, and Sensory Organs), Sapienza University, School of Medicine and Psychology, Sant'Andrea Hospital, Rome, Italy;
² NEUROMED, Pozzilli, Isernia, Italy;
³ NEUROMED, Pozzilli, Isernia, Italy; ; Department of Neuropharmacology, Sapienza University, School of Medicine and Pharmacy, Rome, Italy;
⁴ NESMOS Department (Neuroscience, Mental Health, and Sensory Organs), Sapienza University, School of Medicine and Psychology, Sant'Andrea Hospital, Rome, Italy; ; Centro Lucio Bini, Rome, Italy;
⁵ NESMOS Department (Neuroscience, Mental Health, and Sensory Organs), Sapienza University, School of Medicine and Psychology, Sant'Andrea Hospital, Rome, Italy; ; Centro Lucio Bini, Rome, Italy; ; IRCCS Santa Lucia Foundation, Department of Clinical and Behavioural Neurology, Neuropsychiatry Laboratory, Rome, Italy.

PMID: 24403877
PMCID: PMC3763761
DOI: 10.2174/1570159X113119990037

Abstract

Objectives: To review the role of Wnt pathways in the neurodevelopment of schizophrenia.

Methods: SYSTEMATIC PUBMED SEARCH, USING AS KEYWORDS ALL THE TERMS RELATED TO THE WNT PATHWAYS AND CROSSING THEM WITH EACH OF THE FOLLOWING AREAS: normal neurodevelopment and physiology, neurodevelopmental theory of schizophrenia, schizophrenia, and antipsychotic drug action.

Results: Neurodevelopmental, behavioural, genetic, and psychopharmacological data point to the possible involvement of Wnt systems, especially the canonical pathway, in the pathophysiology of schizophrenia and in the mechanism of antipsychotic drug action. The molecules most consistently found to be associated with abnormalities or in antipsychotic drug action are Akt1, glycogen synthase kinase3beta, and beta-catenin. However, the extent to which they contribute to the pathophysiology of schizophrenia or to antipsychotic action remains to be established.

Conclusions: The study of the involvement of Wnt pathway abnormalities in schizophrenia may help in understanding this multifaceted clinical entity; the development of Wnt-related pharmacological targets must await the collection of more data.

Keywords: Antipsychotic Drugs; Neurodevelopment; Schizophrenia; Wingless (Wnt) signalling..

PubMed Disclaimer

Figures

**Fig. (1)**
Simplified drawing of putative interactions between canonical Wnt and other pathways to illustrate their complex interplay. Dashed lines indicate inhibition, solid lines activation.

See this image and copyright information in PMC

Cited by

Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.
Lecarpentier Y, Claes V, Vallée A, Hébert JL. Lecarpentier Y, et al. Clin Transl Med. 2017 Dec;6(1):14. doi: 10.1186/s40169-017-0144-7. Epub 2017 Apr 12. Clin Transl Med. 2017. PMID: 28405929 Free PMC article. Review.
Rare Variants in Tissue Inhibitor of Metalloproteinase 2 as a Risk Factor for Schizophrenia: Evidence From Familial and Cohort Analysis.
John J, Sharma A, Kukshal P, Bhatia T, Nimgaonkar VL, Deshpande SN, Thelma BK. John J, et al. Schizophr Bull. 2019 Jan 1;45(1):256-263. doi: 10.1093/schbul/sbx196. Schizophr Bull. 2019. PMID: 29385606 Free PMC article.
Single-cell genomics and regulatory networks for 388 human brains.
Emani PS, Liu JJ, Clarke D, Jensen M, Warrell J, Gupta C, Meng R, Lee CY, Xu S, Dursun C, Lou S, Chen Y, Chu Z, Galeev T, Hwang A, Li Y, Ni P, Zhou X; PsychENCODE Consortium; Bakken TE, Bendl J, Bicks L, Chatterjee T, Cheng L, Cheng Y, Dai Y, Duan Z, Flaherty M, Fullard JF, Gancz M, Garrido-Martín D, Gaynor-Gillett S, Grundman J, Hawken N, Henry E, Hoffman GE, Huang A, Jiang Y, Jin T, Jorstad NL, Kawaguchi R, Khullar S, Liu J, Liu J, Liu S, Ma S, Margolis M, Mazariegos S, Moore J, Moran JR, Nguyen E, Phalke N, Pjanic M, Pratt H, Quintero D, Rajagopalan AS, Riesenmy TR, Shedd N, Shi M, Spector M, Terwilliger R, Travaglini KJ, Wamsley B, Wang G, Xia Y, Xiao S, Yang AC, Zheng S, Gandal MJ, Lee D, Lein ES, Roussos P, Sestan N, Weng Z, White KP, Won H, Girgenti MJ, Zhang J, Wang D, Geschwind D, Gerstein M. Emani PS, et al. bioRxiv [Preprint]. 2024 Mar 30:2024.03.18.585576. doi: 10.1101/2024.03.18.585576. bioRxiv. 2024. Update in: Science. 2024 May 24;384(6698):eadi5199. doi: 10.1126/science.adi5199. PMID: 38562822 Free PMC article. Updated. Preprint.
Case Report of Childhood-Onset Psychosis in a Patient with a Known WNT10A Mutation.
Kobza AO, Alenezi S. Kobza AO, et al. J Can Acad Child Adolesc Psychiatry. 2019 Nov;28(3):147-150. Epub 2019 Nov 1. J Can Acad Child Adolesc Psychiatry. 2019. PMID: 31798653 Free PMC article.
Transcriptome Profiling Reveals Novel Candidate Genes Related to Hippocampal Dysfunction in SREBP-1c Knockout Mice.
Ang MJ, Kim J, Lee S, Kim SH, Kim JC, Jeon TI, Im SS, Moon C. Ang MJ, et al. Int J Mol Sci. 2020 Jun 10;21(11):4131. doi: 10.3390/ijms21114131. Int J Mol Sci. 2020. PMID: 32531902 Free PMC article.

See all "Cited by" articles

References

1. Huber G. Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr. Neurol. Psychiatr. 1966;34:409–426.
1. Feinberg I. Schizophrenia caused by a fault in programmed synaptic elimination during adolescence. J. Psychiatr. Res. 1982. 1983;17:319–334. - PubMed
1. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 1987;44:660–669. - PubMed
1. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder. BMJ. 1987;295:681–682. - PMC - PubMed
1. Crow TJ. Positive and negative schizophrenic symptoms and the role of dopamine. Br. J. Psychiatry. 1980;137:383–386. - PubMed

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Neurodevelopment in schizophrenia: the role of the wnt pathways

Affiliations

Neurodevelopment in schizophrenia: the role of the wnt pathways

Authors

Affiliations

Abstract

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials

Miscellaneous